Clinical Trials Browser

Not yet recruiting × Carcinoma, Ovarian Epithelial × 30 days × Clear all

NCT07454018 2026-03-06

Iparomlimab/Tuvonralimab + Standard Chemotherapy and Olaparib in Platinum-Sensitive Recurrent Ovarian Cancer

Phase 2 Not yet recruiting

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms